BIOTRICITY INC. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3b4ca97b-6635-4242-9c74-2c551e500d75/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $16.0M | 2025-04-01 – 2026-03-31 | evidence 0001493152-26-033207 |
| FY 2024 | $13.8M | 2024-04-01 – 2025-03-31 | evidence 0001641172-25-019755 |
| FY 2023 | $12.1M | 2023-04-01 – 2024-03-31 | evidence 0001493152-24-025344 |
| FY 2022 | $9.6M | 2022-04-01 – 2023-03-31 | evidence 0001493152-23-022974 |
| FY 2021 | $7.7M | 2021-04-01 – 2022-03-31 | evidence 0001493152-22-019256 |
| FY 2020 | $3.4M | 2020-04-01 – 2021-03-31 | evidence 0001493152-21-014912 |
| FY 2019 | $1.4M | 2019-04-01 – 2020-03-31 | evidence 0001493152-20-013313 |
| FY 2018 | $398.2k | 2018-04-01 – 2019-03-31 | evidence 0001493152-20-013313 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).